Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

PrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.

“With low uptake of PrEP among the communities most impacted by HIV, this insurance coverage requirement with zero ...

The Bay Area Reporter reports that long-acting injectable PrEP is now to be covered without cost-sharing under Affordable ...

July 23, 2024 — Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global ...

One in eight women will develop invasive breast cancer in their lifetime, which is why regular screenings are so important.

About The Study: Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, with generic tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) being the most frequently prescribed medication ...

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...

Former U.K. foreign aid officials' advice to Prime Minister Keir Starmer. Plus time is running out for the U.N.'s “failing ...

Now more than 40 years since the discovery of the HIV pandemic. 8 The results of this study provide reason for optimism that offering long-acting antiretroviral options for PrEP, as part of a flexible ...

More encouraging news has been announced about the new, twice-yearly PrEP injection currently undergoing trials. Lenacapavir is already in use as a treatment for HIV. However, pharma giant Gilead ...